Agilon Health AGL Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $5.82B-1.9% | $5.93B+0.8% | $5.89B-0.3% | $5.9B-1.5% | $5.99B-1.2% | ||
| $226.81M-4.9% | $238.54M+0.1% | $238.19M-2.8% | $245.12M-5.2% | $258.45M-3.9% | ||
| $28.51M-0.3% | $28.59M+1.7% | $28.12M+4.5% | $26.91M+5.5% | $25.5M+4.2% | ||
| —— | $36.09M+29.0% | $27.96M+40.9% | $19.84M+69.3% | $11.72M+226% | ||
| $6.26B-2.2% | $6.4B+2.1% | $6.26B-0.3% | $6.28B-0.2% | $6.3B-0.9% | ||
| -$437.13M+5.6% | -$463.24M-22.7% | -$377.51M+0.6% | -$379.75M-23.7% | -$307.06M-5.1% | ||
| -7.5%+0.3pp | -7.8%-1.4pp | -6.4%0.0pp | -6.4%-1.3pp | -5.1%-0.3pp | ||
| $6.94M+4.5% | $6.64M+2.2% | $6.5M+3.4% | $6.28M-2.0% | $6.41M+3.7% | ||
| $74.38M+10.0% | $67.62M+97.3% | $34.28M-16.2% | $40.9M+8.0% | $37.86M+9.8% | ||
| -$2.77M-51.2% | -$1.84M— | —— | —— | —— | ||
| -$372.46M+7.8% | -$404.1M-25.8% | -$321.21M+2.0% | -$327.7M-29.2% | -$253.63M-1.9% | ||
| $1.08M-13.4% | $1.25M-25.7% | $1.68M+18.2% | $1.43M-19.9% | $1.78M+22.7% | ||
| -$354.54M+9.4% | -$391.35M-27.0% | -$308.26M+2.3% | -$315.66M-30.5% | -$241.98M+7.0% | ||
| -6.1%+0.5pp | -6.6%-1.4pp | -5.2%+0.1pp | -5.3%-1.3pp | -4%+0.3pp | ||
| —— | —— | —— | —— | -$0.57+7.0% | ||
| $1.18+35.6% | $0.87+100% | -$8,122,999.16+12.7% | -$9,305,999.160.0% | -$9,305,999.16+5.3% | ||
| $1.96+884% | -$0.25-400% | -$0.05+28.6% | -$0.07-164% | $0.11+118% | ||
| $1.97+888% | -$0.25-400% | -$0.05+28.6% | -$0.07-164% | $0.11+118% | ||
| 1.3B0.0% | 1.3B+0.2% | 1.3B+0.2% | 1.3B+0.2% | 1.3B-23.9% | ||
| 1.3B0.0% | 1.3B+0.2% | 1.3B+0.2% | 1.3B+0.2% | 1.3B-23.9% | ||
| $0.82+175% | -$1.09-22.5% | -$0.89+2.2% | -$0.91-24.7% | -$0.73-19.7% | ||
| $0.82+175% | -$1.09-22.5% | -$0.89+2.2% | -$0.91-24.7% | -$0.73-19.7% | ||
| $19M+35.7% | $14M0.0% | $14M0.0% | $14M0.0% | $14M+260% | ||
| —— | $0+100% | -$265.25K+50.0% | -$530.5K+33.3% | -$795.75K+25.0% | ||
| —— | —— | —— | —— | —— | ||
| $5.82B-1.9% | $5.93B+0.8% | $5.89B-0.3% | $5.9B-1.5% | $5.99B-1.2% | ||
| -$437.13M+5.6% | -$463.24M-22.7% | -$377.51M+0.6% | -$379.75M-23.7% | -$307.06M-5.1% | ||
| -$408.62M+6.0% | -$434.64M-24.4% | -$349.39M+1.0% | -$352.84M-25.3% | -$281.57M-5.2% | ||
| -$408.62M+6.0% | -$434.64M-24.4% | -$349.39M+1.0% | -$352.84M-25.3% | -$281.57M-5.2% | ||
| -7%+0.3pp | -7.3%-1.4pp | -5.9%0.0pp | -6%-1.3pp | -4.7%-0.3pp | ||
| -$437.13M+5.6% | -$463.24M-22.7% | -$377.51M+0.6% | -$379.75M-23.7% | -$307.06M-5.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Agilon Health's revenue?
- Agilon Health (AGL) generated $5.8B in revenue over the trailing twelve months, down 2.8% year over year.
- Is Agilon Health profitable?
- Agilon Health is not currently profitable: it reported a net loss of $354.5M over the trailing twelve months, a -6.1% net margin.
- What is Agilon Health's earnings per share?
- Agilon Health's diluted EPS over the trailing twelve months is $1.96.
- Where does Agilon Health's income statement data come from?
- Every line is extracted from Agilon Health's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
